Abstract:
Nano magnetite copper (I) complexes are exceptionally antibacterial, anticancer, anti-inflammatory, and antimicrobial capabilities, which have drawn particular attention as a potential class of medicinal medicines. Nano-magnetic copper complexes [Nano-magnetite-Lys@Cu(PPh3)I] and [Nano-magnetite-Arg@Cu(PPh3)I] with sizes of 12 nm and 15 nm are reported to have undergone a multi-step synthesis and characterization process. Complexes significantly outperformed the conventional medicine cis-platin (IC50=88.91 g/mL) in terms of their ability to inhibit the growth of MCF-7 breast cancer cells, with IC50 values of 104.38 g/mL and 95.81 g/mL, respectively. Both complexes' hyperthermia investigations produced impressive specific absorption rate (SAR) values of 36.83-85.81 W/g and 97.67-125.58 W/g, respectively, at therapeutic temperatures of 48 °C and 43 °C. According to the studies, the combined effects of hyperthermia and chemotherapy can make both complexes a double-edged sword in the treatment of breast cancer. Additionally, they have minimal toxicity, are inexpensive, and quickly undergo redox reactions, which enable a range of ligands to combine to produce stable and biologically effective complexes.
Audience Take Away Notes:
- Audience will learn in vitro anticancer activity of nano-magnetite
- The significant anticancer activities of complexes are attributed to synergistic effect of nano-magnetite supported ligand architecture and Cu metal. this research is useful for evaluating the potential of nano-magnetite for biomedical applications
- The studies reveal that complexes play dual role (anticancer/hyperthermia) against breast cancer cells and can be further explored as a double edged sword for their potent applications in breast cancer therapeutics